(Q50580344)

English

Effects of ribavirin on cytokine production of recall antigens and phytohemaglutinin-stimulated peripheral blood mononuclear cells. (Inhibitory effects of ribavirin on cytokine production).

scientific article published in July 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

Effects of ribavirin on cytokine production of recall antigens and phytohemaglutinin-stimulated peripheral blood mononuclear cells. (Inhibitory effects of ribavirin on cytokine production). (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

1 reference

based on heuristic

inferred from title

author name string

Silvia Sookoian

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

Gustavo Castaño

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

Diego Flichman

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

Jerónimo Cello

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

Annals of hepatology : official journal of the Mexican Association of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

104-107

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical pharmacology of ribavirin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiviral action of ribavirin in chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and long-term tolerance to ribavirin in asymptomatic patients infected with human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ribavirin: efficacy in the treatment of murine autoimmune disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ribavirin in the treatment of SARS: A new trick for an old drug?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of lymphocyte proliferative responses by ribavirin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive activity of ribavirin using the rabbit skin allograft model

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ribavirin inhibits mast cell mediator release.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15505595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/15505595

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50580344&oldid=1394165401"